Stockscreener 앱 받기
135.06
0.03%
0.095
전일 마감가:
$134.97
열려 있는:
$135
하루 거래량:
828.14K
Relative Volume:
0.22
시가총액:
$28.55B
수익:
$398.11M
순이익/손실:
$-1.03B
주가수익비율:
-23.74
EPS:
-5.69
순현금흐름:
$-868.57M
1주 성능:
+2.37%
1개월 성능:
+28.58%
6개월 성능:
+65.55%
1년 성능:
+76.88%
1일 변동 폭
$134.39
$135.68
1주일 범위
$128.02
$136.90
52주 변동 폭
$60.40
$136.90
Insmed Inc Stock (INSM) Company Profile
명칭
Insmed Inc
전화
908-977-9900
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
INSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
135.07 | 28.44B | 398.11M | -1.03B | -868.57M | -5.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.18 | 99.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.93 | 62.21B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.40 | 59.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
711.55 | 43.33B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.36 | 35.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-20 | 개시 | William Blair | Outperform |
| 2025-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 개시 | Jefferies | Buy |
| 2025-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-23 | 개시 | Truist | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-07-26 | 개시 | Guggenheim | Buy |
| 2022-12-09 | 개시 | Mizuho | Buy |
| 2022-12-07 | 개시 | Barclays | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Buy |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2021-12-06 | 개시 | JP Morgan | Overweight |
| 2021-10-19 | 재개 | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-10-12 | 재개 | Stifel | Buy |
| 2019-09-03 | 개시 | Goldman | Buy |
| 2019-04-09 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-15 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-01-02 | 개시 | Canaccord Genuity | Buy |
| 2018-08-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 개시 | Goldman | Neutral |
| 2018-04-23 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 개시 | Morgan Stanley | Overweight |
| 2018-01-18 | 개시 | Credit Suisse | Neutral |
| 2017-09-05 | 재확인 | Evercore ISI | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Robert W. Baird | Outperform |
| 2016-03-15 | 개시 | Stifel | Buy |
| 2015-11-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2015-10-06 | 재확인 | H.C. Wainwright | Buy |
| 2015-06-09 | 개시 | Citigroup | Neutral |
| 2014-03-26 | 재확인 | HC Wainwright | Buy |
모두보기
Insmed Inc 주식(INSM)의 최신 뉴스
Signal strength of Insmed Incorporated stock in tech scannersWeekly Loss Report & Precise Swing Trade Entry Alerts - Newser
Should you wait for a breakout in Insmed IncorporatedJuly 2025 Outlook & Short-Term High Return Strategies - Newser
What high frequency data says about Insmed IncorporatedBreakout Watch & Precise Swing Trade Entry Alerts - Newser
Is Insmed Incorporated forming a reversal pattern2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - Newser
Intraday pattern recognizer results for Insmed Incorporated2025 Major Catalysts & High Accuracy Trade Alerts - Newser
Is this a good reentry point in Insmed IncorporatedJuly 2025 Highlights & Safe Swing Trade Setup Alerts - Newser
Using AI based signals to follow Insmed IncorporatedJuly 2025 Summary & Daily Technical Forecast Reports - Newser
Relative strength of Insmed Incorporated in sector analysisGlobal Markets & Consistent Profit Trading Strategies - Newser
Analyzing net buyer seller activity in Insmed IncorporatedQuarterly Portfolio Report & Fast Momentum Entry Tips - Newser
Predicting Insmed Incorporated trend using moving averages2025 Winners & Losers & Verified Technical Signals - Newser
What Fibonacci levels say about Insmed Incorporated reboundWeekly Gains Summary & Smart Money Movement Alerts - Newser
Is Insmed Incorporated still worth holding after the dipMarket Performance Summary & AI Forecasted Entry and Exit Points - Newser
Exit strategy if you’re trapped in Insmed IncorporatedJuly 2025 Breakouts & Weekly High Return Opportunities - Newser
Is Insmed Incorporated stock entering bullish territoryMarket Performance Recap & Low Drawdown Investment Ideas - Newser
Has Insmed Incorporated found a price floor2025 Fundamental Recap & Technical Buy Zone Confirmation - Newser
Insmed Shares Soar 0.33% on $240M Volume (403rd) as FDA Approval and Strategic Deals Drive Growth - AInvest
Is it time to cut losses on Insmed IncorporatedJuly 2025 Institutional & Intraday High Probability Alerts - Newser
Insmed stock hits 52-week high at 136.42 USD - Investing.com
Analyzing Insmed Incorporated with risk reward ratio chartsTrade Ideas & Scalable Portfolio Growth Methods - Newser
Full technical analysis of Insmed Incorporated stockMarket Trend Report & Verified Stock Trade Ideas - Newser
What to do if you’re stuck in Insmed IncorporatedJuly 2025 Update & Verified Momentum Stock Watchlist - Newser
Insmed Announces FDA Approval For Drug To Treat Chronic Lung Disease - MSN
How sentiment analysis helps forecast Insmed IncorporatedQuarterly Trade Report & Smart Swing Trading Techniques - Newser
Insmed's 1.79% Surge on $0.27B Volume Ranks 365th as Sector Trends Drive Quiet Rally - AInvest
Using R and stats models for Insmed Incorporated forecastingJuly 2025 Volume & Community Consensus Picks - Newser
Custom watchlist performance reports with Insmed IncorporatedJuly 2025 Catalysts & Smart Allocation Stock Reports - Newser
Is This a Bottoming Phase for Insmed Incorporated getLinesFromResByArray error: size == 0 - thegnnews.com
Institutional scanner results for Insmed Incorporated2025 Growth vs Value & Weekly Market Pulse Updates - Newser
Will Insmed Incorporated outperform the marketPortfolio Value Summary & Intraday High Probability Setup Alerts - Newser
Bronchiectasis Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights By DelveInsight | SolAeroMed, Insmed, NovaBiotics Ltd, Synspira Therapeutics, Parion - Barchart.com
Is Insmed Incorporated showing signs of accumulationTake Profit & Growth Focused Stock Pick Reports - Newser
Insmed Inc (INSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Insmed Inc 주식 (INSM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Adsett Roger | Chief Operating Officer |
Aug 19 '25 |
Sale |
127.58 |
25,000 |
3,189,586 |
105,637 |
| Lewis William | Chair and CEO |
Aug 18 '25 |
Option Exercise |
10.85 |
6,865 |
74,485 |
240,789 |
| Lewis William | Chair and CEO |
Aug 18 '25 |
Sale |
128.40 |
6,865 |
881,470 |
233,924 |
1.38%
3.88%
자본화:
|
볼륨(24시간):